作者：
Stephanie J,Lax [1]
;
Eleanor,Van Vogt [2]
;
Bridget,Candy [3]
;
Lloyd,Steele [4]
;
Clare,Reynolds [5]
;
Beth,Stuart [6]
;
Roses,Parker [7]
;
Emma,Axon [8]
;
Amanda,Roberts [9]
;
Megan,Doyle [1]
;
Derek K,Chu [10]
;
Masaki,Futamura [11]
;
Miriam,Santer [6]
;
Hywel C,Williams [1]
;
Suzie,Cro [2]
;
Aaron M,Drucker [12]
;
Robert J,Boyle [13]
作者单位：
Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK.
[1]
Imperial Clinical Trials Unit, Imperial College London, London, UK.
[2]
Department of Dermatology, Royal Free Hospital, London, UK.
[3]
Wellcome Sanger Institute, Cambridge, UK.
[4]
School of Public Health, Physiotherapy and Sports Science, University College Dublin, Dublin, Ireland.
[5]
Primary Care and Population Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
[6]
Cochrane MOSS Network, c/o Cochrane Pain Palliative and Supportive Care Group, Oxford, UK.
[7]
Cochrane Methods Support Unit, Cochrane, London, UK.
[8]
Nottingham Support Group for Carers of Children With Eczema, Nottingham, UK.
[9]
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.;Department of Health Research Methods, Evidence & Impact, McMaster University, Hamilton, Ontario, Canada.
[10]
Department of Pediatrics, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
[11]
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.;Department of Medicine, Research and Innovation Institute, Women's College Hospital, Toronto, Ontario, Canada.
[12]
Section of Inflammation and Repair, National Heart & Lung Institute, Imperial College London, London, UK.
[13]
DOI
10.1111/cea.14556
PMID
39219446
发布时间
2024-12-16
换一批
换一批
